Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:pharmaceuticals
|
gptkbp:acquisition |
gptkb:Samsung_Biologics
|
gptkbp:collaboration |
gptkb:Amgen
|
gptkbp:employees |
over 500
|
gptkbp:focus |
biosimilars
|
gptkbp:founded |
gptkb:2012
|
gptkbp:founder |
gptkb:Samsung_Group
|
gptkbp:headquarters |
gptkb:Incheon,_South_Korea
|
https://www.w3.org/2000/01/rdf-schema#label |
Samsung Bioepis
|
gptkbp:market |
global
|
gptkbp:parent_company |
gptkb:Samsung_Biologics
|
gptkbp:partnership |
gptkb:Merck_&_Co.
|
gptkbp:product |
gptkb:Biosimilars
gptkb:SB5 gptkb:SB8 gptkb:SB9 SB45 SB10 SB11 SB12 SB16 SB18 SB19 SB2 SB22 SB28 SB3 SB31 SB33 SB34 SB36 SB37 SB38 SB4 SB40 SB41 SB48 SB49 SB50 SB20 SB13 SB14 SB15 SB17 SB21 SB23 SB24 SB25 SB26 SB27 SB29 SB30 SB32 SB35 SB39 SB42 SB43 SB44 SB46 SB47 |
gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:EMA |
gptkbp:research_and_development |
biologics
|
gptkbp:bfsParent |
gptkb:Biogen
|
gptkbp:bfsLayer |
4
|